Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus
disease 2019 (COVID-19); however, rebound after treatment has been reported. We …
被引用次数：5 相关文章

Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - … Diseases: an Official …, 2024 - europepmc.org
Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus disease
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
[HTML] nih.gov

[HTML][HTML] Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - … diseases: an official …, 2024 - ncbi.nlm.nih.gov
Background: Nirmatrelvir/ritonavir (N/R) reduces severe outcomes among patients with
COVID-19; however, rebound after treatment has been reported. We compared symptom …

Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated …

SE Smith-Jeffcoat, JE Biddle… - … publication of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus disease
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
[HTML] oup.com

[HTML][HTML] Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus
disease 2019 (COVID-19); however, rebound after treatment has been reported. We …
[HTML] cdc.gov

[HTML][HTML] Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - … infectious diseases: an …, 2024 - stacks.cdc.gov
Background: Nirmatrelvir/ritonavir (N/R) reduces severe outcomes among patients with
COVID-19; however, rebound after treatment has been reported. We compared symptom …
[HTML] cdc.gov

[HTML][HTML] Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated …

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - … infectious diseases: an …, 2024 - stacks.cdc.gov
Background: Nirmatrelvir/ritonavir (N/R) reduces severe outcomes among patients with
COVID-19; however, rebound after treatment has been reported. We compared symptom …

Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals.

SE Smith-Jeffcoat, JE Biddle, HK Talbot… - … Diseases: an Official …, 2023 - europepmc.org
Nirmatrelvir/ritonavir (N/R) reduces severe outcomes among patients with COVID-19;
however, rebound after treatment has been reported. We compared symptom and viral …